Accelerating Clinical Trials in the European Union (ACT EU)

3 February 2023 – the EMA published the priority action 3 concept paper: an EU multi-stakeholder platform for improving clinical trials.

This paper describes a proposal for the creation of a multi-stakeholder platform (MSP) that aims to promote dialogue and collaboration for improving clinical trials in the EU. The success of clinical trials relies on a multitude of stakeholders. The creation of a common platform will provide further opportunities for interactions between stakeholders, therefore promoting a shared understanding of the respective roles, needs and perspectives.

Read the pdf 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /